93 results
8-K
EX-99.1
NVRO
Nevro Corp
7 May 24
Nevro Reports First-Quarter 2024 Financial Results
4:11pm
. In addition to his current responsibilities, which include leading the company’s manufacturing processes and innovation, research and development …
Cost of revenue
Gross profit
Operating expenses:
Research and development
Sales, general and administrative
Amortization of intangibles
Change in fair
8-K
EX-99.1
NVRO
Nevro Corp
21 Feb 24
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
4:09pm
Ended
December 31,
(unaudited)
Revenue
Cost of revenue
Gross profit
Operating expenses:
Research and development
Sales, general and administrative
8-K
EX-10.1
0g8sh5w
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
8-K
EX-2.1
vf02e9czmb4k1v
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
8-K
EX-99.1
ucsfgbd
1 Nov 23
Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
4:07pm
8-K
EX-99.1
3sxxqd2i bvsy8hgd0v4
1 Aug 23
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
4:10pm
8-K
EX-99.1
0oyy0ko
26 Apr 23
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
4:13pm
8-K
EX-99.1
7apwm
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
EX-99.1
rdrnskvn hlmhd
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm